HCA Healthcare (NYSE:HCA) Issues FY 2026 Earnings Guidance

HCA Healthcare (NYSE:HCA) updated its FY 2026 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 28.700-30.500 for the period, compared to the consensus EPS estimate of 30.170. The company issued revenue guidance of $77.0 billion-$79.5 billion, compared to the consensus revenue estimate of $78.6 billion. HCA Healthcare also updated its Q2 2026 guidance to 7.590-7.590 EPS.

HCA Healthcare Trading Down 3.9%

HCA stock opened at $390.81 on Tuesday. HCA Healthcare has a one year low of $330.00 and a one year high of $556.52. The firm has a 50-day moving average of $396.68 and a two-hundred day moving average of $459.73. The firm has a market capitalization of $86.70 billion, a PE ratio of 13.44, a P/E/G ratio of 1.29 and a beta of 1.12.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, April 24th. The company reported $7.15 EPS for the quarter, missing the consensus estimate of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The firm had revenue of $19.11 billion during the quarter, compared to analysts’ expectations of $19.09 billion. During the same quarter last year, the company posted $6.45 EPS. The firm’s revenue was up 4.3% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts anticipate that HCA Healthcare will post 30.07 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th were given a dividend of $0.78 per share. The ex-dividend date was Tuesday, June 16th. This represents a $3.12 dividend on an annualized basis and a yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is presently 10.73%.

Wall Street Analysts Forecast Growth

Several equities analysts have weighed in on the company. Oppenheimer lowered their target price on HCA Healthcare from $540.00 to $520.00 and set an “outperform” rating on the stock in a research note on Monday, April 27th. Truist Financial set a $413.00 price objective on shares of HCA Healthcare in a research note on Thursday, June 4th. Argus decreased their target price on shares of HCA Healthcare from $560.00 to $500.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Wells Fargo & Company cut their price objective on HCA Healthcare from $436.00 to $428.00 and set an “equal weight” rating for the company in a report on Monday. Finally, Robert W. Baird lowered their target price on HCA Healthcare from $450.00 to $442.00 and set a “neutral” rating on the stock in a research note on Wednesday, April 15th. Fourteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $496.77.

Institutional Investors Weigh In On HCA Healthcare

Several institutional investors and hedge funds have recently bought and sold shares of the business. Brighton Jones LLC bought a new stake in HCA Healthcare in the fourth quarter valued at about $1,021,000. NewEdge Advisors LLC grew its stake in HCA Healthcare by 11.9% during the first quarter. NewEdge Advisors LLC now owns 3,859 shares of the company’s stock worth $1,334,000 after buying an additional 409 shares during the last quarter. Sivia Capital Partners LLC boosted its stake in HCA Healthcare by 5.5% in the second quarter. Sivia Capital Partners LLC now owns 630 shares of the company’s stock worth $241,000 after purchasing an additional 33 shares in the last quarter. Jump Financial LLC bought a new stake in HCA Healthcare during the 2nd quarter worth about $2,073,000. Finally, Sei Investments Co. grew its stake in shares of HCA Healthcare by 56.3% during the second quarter. Sei Investments Co. now owns 136,589 shares of the company’s stock valued at $52,328,000 after purchasing an additional 49,214 shares during the last quarter. Institutional investors own 62.73% of the company’s stock.

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.